Sign inJoin waitlistJoin the waitlist

MS

Michael Stecher

Family Medicine

Credentials: · ·

History

Family Medicine
2002–2005
University of Kansas School of Medicine
1998–2002

Research

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2…
The Lancet Oncology · 2023 · 214 citations
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
The Lancet Oncology · 2014 · 174 citations
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
Investigational New Drugs · 2015 · 57 citations

Razelle Kurzrock
3 papers
Apostolia Tsimberidou
2 papers
Aung Naing
2 papers
David Hong
2 papers
FJ
Filip Janku
2 papers
GF
Gerald Falchook
2 papers
JW
Jennifer Wheler
2 papers
Johann Gudjonsson
2 papers
John Strickler
2 papers
Kimmie Ng
2 papers
KC
Kyle Coleman
2 papers
Sarina Piha-Paul
2 papers